Anabolic Steroids Market Share

  • Report ID: 5986
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Anabolic Steroids Market Share

North American Market Forecast

Anabolic steroids market in North America region is attributed to hold largest revenue share of about 33% during the forecast period. The market for anabolic steroids is anticipated to be dominated by North America due to the region's increasing incidence of breast cancer and increased healthcare spending, which will also accelerate the market's growth pace. There will be roughly 310,720 new instances of invasive breast cancer detected in females. There will be roughly 56,500 new diagnoses of ductal carcinoma in situ (DCIS). There will be 42,250 female breast cancer deaths. Moreover, the anabolic steroids market growth rate in this region will also be accelerated by the expanding presence of significant key players and the increased use of innovative technologies.

APAC Market Statistics

Anabolic steroids market in Asia Pacific region is projected to hold second largest revenue share of about 30% during the forecast period.  The region's rising level of disposable income is the reason behind the expansion of the anabolic steroid business there. Additionally, the expansion of the healthcare sector and the growing number of generic medicine manufacturers will accelerate the growth rate of this industry. In 2018, more than 90% of the Indian pharmaceutical industry was made up of generic medications. In contrast, generics made up just about 29% of the Taiwanese pharmaceutical industry that year.

Research Nester
Anabolic Steroids Market size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5986
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anabolic steroids is evaluated at USD 17.71 billion.

The anabolic steroids market size was valued at USD 16.42 billion in 2024 and is set to exceed USD 55.36 billion by 2037, registering over 9.8% CAGR during the forecast period i.e., between 2025-2037. Increasing geriatric population and prevalence of hypogonadism in men will drive the market growth.

North America industry is expected to account for largest revenue share of 33% by 2037, impelled by increasing incidence of breast cancer in the region.

The major players in the market include Mylan N.V., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Merck & Co., Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample